LivaNova (LIVN) Debt Ratio (2015 - 2026)

LivaNova (LIVN) posted Debt Ratio of 0.11 for Q1 2026, down 30.03% sequentially from 0.16 in Q4 2025, and down 58.63% YoY from 0.28 in Q1 2025.

LivaNova (LIVN) Debt Ratio (2015 - 2026) Analysis & Trends

LivaNova has reported Debt Ratio for 12 years, with the latest figure at 0.11 in Q1 2026.

Quarterly Debt Ratio fell 58.63% year-over-year to 0.11 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.11 (down 58.63% YoY) and the FY2025 annual result came in at 0.16, down 41.87% from the prior year.
Debt Ratio slipped to 0.11 in Q1 2026 per LIVN's latest filing, from 0.16 in the prior quarter.
Over five years, Debt Ratio peaked at 0.73 in Q2 2024 and troughed at 0.11 in Q1 2026.
A 5-year average of 0.25 and a median of 0.25 in 2024 frame the typical range for Debt Ratio.
The sharpest annual moves came in 2024 and 2025: Debt Ratio soared 182.75% in 2024, then plunged 76.5% in 2025.
Over 5 years, Debt Ratio stood at 0.24 in 2022, then increased by 5.37% to 0.25 in 2023, then climbed by 13.12% to 0.28 in 2024, then tumbled by 41.87% to 0.16 in 2025, then sank by 30.03% to 0.11 in 2026.
According to Business Quant data, Debt Ratio over the past three periods registered 0.11, 0.16, and 0.17 for Q1 2026, Q4 2025, and Q3 2025 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Abbott Laboratories	198.93 Bn	193.33 Bn	7.27 Bn	0.30
2	Stryker	127.82 Bn	124.35 Bn	4.50 Bn	0.31
3	Medtronic	118.80 Bn	109.58 Bn	6.41 Bn	0.30
4	Boston Scientific	73.38 Bn	72.84 Bn	3.85 Bn	0.28
5	Edwards Lifesciences	51.95 Bn	47.70 Bn	1.35 Bn	0.04
6	Dexcom	34.44 Bn	32.50 Bn	830.00 Mn	-
7	GE HealthCare Technologies	33.91 Bn	31.80 Bn	2.18 Bn	0.27
8	Koninklijke Philips	26.36 Bn	23.04 Bn	4.55 Bn	0.28
9	Steris	23.10 Bn	22.62 Bn	684.20 Mn	0.18
10	LivaNova	4.29 Bn	3.77 Bn	273.67 Mn	0.11

Download Data